Omics sciences provide potential to address key questions relevant to the chemical and pharmaceutical industry in environmental effects, ecotoxicity, environmental fate and antimicrobial resistance. AstraZeneca will be willing to partner with fellows leveraging ‘Omics and informatics develops to advance ecological knowledge and understanding these areas of science.

Read more >

Date: May 23, 2013